LipoScience, Inc.

LipoScience, Inc. is a publicly traded company as of January 2013.
Below is PrivCo's archived report for LipoScience, Inc.

What's included with your PrivCo Report Purchase:

Next Actions on LipoScience, Inc.:

Business Summary

LipoScience is a privately-held company that operates in the lab services industry. LipoScience headquarters are located in Raleigh, North Carolina.

Recent News, Updates, and Analysis

WEEK'S IPO REVIEW: 2 High Profile IPOs On Tap: (1) BAIN CAPITAL Backed BRIGHT HORIZONS Eyes $202M IPO To Pay Down LBO-Related Debt; (2) LIPOSCIENCE Aims To Go Public In 2013's 1st Health-Care IPO, Expected to Set Tone For Sector's IPOs This Year
Jan. 2013 January 24, 2013 2:00 am EST - PrivCo analyzes the two anticipated IPOs for this week: Bright Horizons Family Solutions, Inc., and LipoScience, Inc. … Read More »

Overview & Corporate Organization

Basic Information

Year Founded:	1997
Fiscal Year End:	12/31
1YR Revenue Growth Rate:	View %
3YR Revenue Growth Rate (CAGR):	View %
City:	Raleigh
State/Province:	North Carolina
Country:	United States
Phone:	View
Fax:	View
Website:	www.liposcience.com

Industry Information

Industry Codes

PICS™:	700316™, 1501522™
NAICS:	View
SIC:	View

PrivCo Industries (Sector > Industry > Sub-Industry)

Healthcare > Health Care Providers & Related Medical Services > Lab Services

Technology > Software > Health & Medical Software

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

Ownership

PrivCo's Ownership table displays who owns LipoScience, Inc., including owner name, each type of owner (whether family, individual, private equity firm, etc.)

Owner Name	Type of Owner	% Ownership Stake
View	View	View
View	View	View
View	View	View
View	View	View
View	View	View
View	View	View

Charts, Financials, and Statistics (Table Format)

Below are LipoScience, Inc. financials and other business metrics displayed in table format.
Copy & Paste Financials Into Spreadsheet or

Export All LipoScience, Inc. Financials To Excel

All data before 2006 is completely free to view! To access data from 2006 onward:

Worldwide
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Washington, D.C.
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Canada
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Europe (all countries)
UK
Germany
France
Italy
Europe (excluding UK)
Asia-Pacific (all countries)
Australia
China
Hong Kong
India
South Korea
Taiwan
Japan
Asia-Pacific (excluding India)
Latin America (all countries)
Middle East & Africa (all countries)

Get Full Access To This Report	or	Upgrade to PrivCo Premium
$99 Single Company Access		Instant Full Site-Wide Access *Currently 50% Off Until May. 31!*

Income Statement	2011	2010	2009	2008
Revenues	View	View	View	View
Cost of Goods and Services Sold	View	View	View	View
Gross Profit	View	View	View	View
Selling and Marketing Expenses	View	View	View	View
General and Administrative Expenses	View	View	View	View
Research and Development Expense (Excluding In - Process)	View	View	View	View
Other Operating Income Expense	View	View	View	View
Total Operating Expenses excluding costs	View	View	View	View
Operating Income/(Loss)	View	View	View	View
Interest Expense	View	View	View	View
Interest Income	View	View	View	View
Gain/(Loss) on Disposition of Property	View	View	View
Non-operating Income/(Expense) - Other	View	View	View	View
Non-operating Income/(Expense)	View	View	View	View
Income/(Loss) from Continuing Operations Before Income Taxes	View	View	View	View
Provision for Income Taxes	View	View	View	View
Extinguishment of Debt	View	View	View	View
Net Income (Loss)	View	View	View	View
Preferred Stock Dividends	View	View	View	View
Other Preferred Stock Dividends and Adjustments	View	View	View	View
Net Income Applicable to Common Stockholders	View	View	View	View

Balance Sheet	2011	2010	2009
Cash and Cash Equivalents	View	View	View
Net Accounts Receivable Trade	View	View	View
Prepaid Expenses	View	View	View
Current Assets	View	View	View
Net Property, Plant and Equipment	View	View	View
Net Intangible Assets	View	View	View
Deferred Financing Costs	View	View	View
Other Deferred Long Term Asset Charges	View	View	View
Restricted Cash	View	View	View
Noncurrent Other Assets	View	View	View
Assets	View	View	View
Accounts Payable	View	View	View
Accrued Expenses	View	View	View
Current Line of Credit	View	View
Current Portion of Long-Term Debt	View	View	View
Current Capital Lease Obligations	View	View	View
Current Other Liabilities	View	View	View
Current Liabilities	View	View	View
Long-Term Debt	View	View	View
Capital Lease Obligations - Long-Term			View
Noncurrent Warranty and Related Accruals	View	View
Noncurrent Other Liabilities	View	View	View
Liabilities	View	View	View
Redeemable Convertible Preferred Stock Obligations	View	View	View
Total Temporary Equity	View	View
Convertible Preferred Stock - Value (Excluding Additional Paid in Capital)	View	View	View
Common Stock - Value (Excluding Additional Paid in Capital)	View	View	View
Additional Paid in Capital	View	View	View
Retained Earnings	View	View	View
Stockholders' Equity	View	View	View
Liabilities and Stockholders' Equity	View	View	View

Cash Flow Statement	2011	2010	2009	2008
Operating Activities Beginning Net Income	View	View	View	View
Depreciation and Amortization	View	View	View	View
Gain/(Loss) on Sale/Retirement of Property, Plant and Equipment	View	View	View	View
Adjustment for Equity Based Compensation Expense	View	View	View	View
Adjustment Write Off of Intangible Asset Excluding Goodwill				View
Adjustment Extraordinary Items	View	View	View	View
Other Adjustments to Common Stockholders' Net Income - Increase/(Decrease)	View	View	View	View
Change Accounts Receivable	View	View	View	View
Change Prepaid Expenses Other Current Assets	View	View	View	View
Increase/(Decrease) in Accounts Payable and Accrued Expenses	View	View	View	View
Increase/(Decrease) in Other Non-operating Liabilities	View	View	View	View
Net Cash Flows Provided By/(Used In) Operating Activities	View	View	View	View
Purchase of Property, Plant and Equipment	View	View	View	View
Net Proceeds from Sale of Short-Term Investments				View
Purchase Intangible Assets	View	View	View	View
Proceeds from Sale of Property, Plant and Equipment	View	View	View	View
Net Cash Flows Provided By/(Used In) Investing Activities	View	View	View	View
Net Change Restricted Cash	View	View	View	View
Proceeds from Lines of Credit	View	View	View
Net Proceeds from Issuance of Long-Term Debt and Capital Securities	View	View	View	View
Reduction of Capital Lease Obligations	View	View	View	View
Repayments of Long-Term Debt and Capital Securities	View	View	View	View
Financing Costs				View
Proceeds from Stock Options Exercised	View	View	View	View
Stock Issuance Costs	View	View	View	View
Cash Provided by/(Used in) Financing Activities - Other	View	View	View
Net Cash Flows Provided By/(Used In) Financing Activities	View	View	View	View
Increase/(Decrease) in Cash and Cash Equivalents	View	View	View	View
Cash and cash equivalents at the beginning of the year	View	View	View	View
Total Cash and cash equivalents at the end of the year	View	View	View	View
Income Taxes Paid	View	View	View	View
Cash Interest Expense	View	View	View	View
Supplemental Property Plant Equipment Acquired				View
Supplemental Other Net	View	View	View	View

Financial Notes:
*	LipoScience, Inc. fiscal year end: 12/31

	Date	Deal Type	Action	Resulting Status	Valuation	Amount Raised	Public Ticker
Details	Jan. 2013	View	View	View¹	View	View	View

1	Originally filed to offer 5...Read More →
	Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

Choose Region(s):
Or Enter Location (US, CAN, UK): within miles
Annual Revenues search is available on PrivCo Premium. Upgrade to PrivCo Premium Subscription Annual Revenues:
Industry:
Go to Advanced Search

LipoScience, Inc.

Business Summary

Recent News, Updates, and Analysis

Overview & Corporate Organization

Basic Information

Industry Information

Industry Codes

PrivCo Industries (Sector > Industry > Sub-Industry)

Ownership

Charts, Financials, and Statistics (Table Format)

Charts, Financials, and Statistics (Graphs)

LipoScience, Inc. Revenues ($ MM): (Displayed as graph)

LipoScience, Inc. Cost of Goods and Services Sold ($ MM): (Displayed as graph)

LipoScience, Inc. Gross Profit ($ MM): (Displayed as graph)

LipoScience, Inc. Selling and Marketing Expenses ($ MM): (Displayed as graph)

LipoScience, Inc. General and Administrative Expenses ($ MM): (Displayed as graph)

LipoScience, Inc. Research and Development Expense (Excluding In - Process) ($ MM): (Displayed as graph)

LipoScience, Inc. Other Operating Income Expense ($ MM): (Displayed as graph)

LipoScience, Inc. Total Operating Expenses excluding costs ($ MM): (Displayed as graph)

LipoScience, Inc. Operating Income/(Loss) ($ MM): (Displayed as graph)

LipoScience, Inc. Interest Expense ($): (Displayed as graph)

LipoScience, Inc. Interest Income ($): (Displayed as graph)

LipoScience, Inc. Non-operating Income/(Expense) - Other ($): (Displayed as graph)

LipoScience, Inc. Non-operating Income/(Expense) ($): (Displayed as graph)

LipoScience, Inc. Income/(Loss) from Continuing Operations Before Income Taxes ($ MM): (Displayed as graph)

LipoScience, Inc. Provision for Income Taxes ($): (Displayed as graph)

LipoScience, Inc. Extinguishment of Debt ($): (Displayed as graph)

LipoScience, Inc. Net Income (Loss) ($ MM): (Displayed as graph)

LipoScience, Inc. Preferred Stock Dividends ($ MM): (Displayed as graph)

LipoScience, Inc. Other Preferred Stock Dividends and Adjustments ($ MM): (Displayed as graph)

LipoScience, Inc. Net Income Applicable to Common Stockholders ($ MM): (Displayed as graph)

LipoScience, Inc. Cash and Cash Equivalents ($ MM): (Displayed as graph)

LipoScience, Inc. Net Accounts Receivable Trade ($ MM): (Displayed as graph)

LipoScience, Inc. Prepaid Expenses ($): (Displayed as graph)

LipoScience, Inc. Current Assets ($ MM): (Displayed as graph)

LipoScience, Inc. Net Property, Plant and Equipment ($ MM): (Displayed as graph)

LipoScience, Inc. Net Intangible Assets ($): (Displayed as graph)

LipoScience, Inc. Deferred Financing Costs ($): (Displayed as graph)

LipoScience, Inc. Other Deferred Long Term Asset Charges ($ MM): (Displayed as graph)

LipoScience, Inc. Restricted Cash ($ MM): (Displayed as graph)

LipoScience, Inc. Noncurrent Other Assets ($): (Displayed as graph)

LipoScience, Inc. Assets ($ MM): (Displayed as graph)

LipoScience, Inc. Accounts Payable ($ MM): (Displayed as graph)

LipoScience, Inc. Accrued Expenses ($ MM): (Displayed as graph)

LipoScience, Inc. Current Portion of Long-Term Debt ($ MM): (Displayed as graph)

LipoScience, Inc. Current Capital Lease Obligations ($): (Displayed as graph)

LipoScience, Inc. Current Other Liabilities ($): (Displayed as graph)

LipoScience, Inc. Current Liabilities ($ MM): (Displayed as graph)

LipoScience, Inc. Long-Term Debt ($ MM): (Displayed as graph)

LipoScience, Inc. Noncurrent Warranty and Related Accruals ($): (Displayed as graph)

LipoScience, Inc. Noncurrent Other Liabilities ($ MM): (Displayed as graph)

LipoScience, Inc. Liabilities ($ MM): (Displayed as graph)

LipoScience, Inc. Redeemable Convertible Preferred Stock Obligations ($ MM): (Displayed as graph)

LipoScience, Inc. Total Temporary Equity ($ MM): (Displayed as graph)

LipoScience, Inc. Convertible Preferred Stock - Value (Excluding Additional Paid in Capital) ($): (Displayed as graph)

LipoScience, Inc. Common Stock - Value (Excluding Additional Paid in Capital) ($): (Displayed as graph)

LipoScience, Inc. Additional Paid in Capital ($ MM): (Displayed as graph)

LipoScience, Inc. Retained Earnings ($ MM): (Displayed as graph)

LipoScience, Inc. Stockholders' Equity ($ MM): (Displayed as graph)

LipoScience, Inc. Liabilities and Stockholders' Equity ($ MM): (Displayed as graph)

LipoScience, Inc. Operating Activities Beginning Net Income ($ MM): (Displayed as graph)

LipoScience, Inc. Depreciation and Amortization ($ MM): (Displayed as graph)

LipoScience, Inc. Gain/(Loss) on Sale/Retirement of Property, Plant and Equipment ($): (Displayed as graph)

LipoScience, Inc. Adjustment for Equity Based Compensation Expense ($): (Displayed as graph)

LipoScience, Inc. Adjustment Extraordinary Items ($ MM): (Displayed as graph)

LipoScience, Inc. Other Adjustments to Common Stockholders' Net Income - Increase/(Decrease) ($): (Displayed as graph)

LipoScience, Inc. Change Accounts Receivable ($ MM): (Displayed as graph)

LipoScience, Inc. Change Prepaid Expenses Other Current Assets ($): (Displayed as graph)

LipoScience, Inc. Increase/(Decrease) in Accounts Payable and Accrued Expenses ($ MM): (Displayed as graph)

LipoScience, Inc. Increase/(Decrease) in Other Non-operating Liabilities ($): (Displayed as graph)

LipoScience, Inc. Net Cash Flows Provided By/(Used In) Operating Activities ($ MM): (Displayed as graph)

LipoScience, Inc. Purchase of Property, Plant and Equipment ($ MM): (Displayed as graph)

LipoScience, Inc. Purchase Intangible Assets ($): (Displayed as graph)

LipoScience, Inc. Proceeds from Sale of Property, Plant and Equipment ($): (Displayed as graph)

LipoScience, Inc. Net Cash Flows Provided By/(Used In) Investing Activities ($ MM): (Displayed as graph)

LipoScience, Inc. Net Change Restricted Cash ($): (Displayed as graph)

LipoScience, Inc. Net Proceeds from Issuance of Long-Term Debt and Capital Securities ($ MM): (Displayed as graph)

LipoScience, Inc. Reduction of Capital Lease Obligations ($): (Displayed as graph)

LipoScience, Inc. Repayments of Long-Term Debt and Capital Securities ($ MM): (Displayed as graph)

LipoScience, Inc. Proceeds from Stock Options Exercised ($): (Displayed as graph)

LipoScience, Inc. Revenues ($ MM):
(Displayed as graph)

LipoScience, Inc. Cost of Goods and Services Sold ($ MM):
(Displayed as graph)

LipoScience, Inc. Gross Profit ($ MM):
(Displayed as graph)

LipoScience, Inc. Selling and Marketing Expenses ($ MM):
(Displayed as graph)

LipoScience, Inc. General and Administrative Expenses ($ MM):
(Displayed as graph)

LipoScience, Inc. Research and Development Expense (Excluding In - Process) ($ MM):
(Displayed as graph)

LipoScience, Inc. Other Operating Income Expense ($ MM):
(Displayed as graph)

LipoScience, Inc. Total Operating Expenses excluding costs ($ MM):
(Displayed as graph)

LipoScience, Inc. Operating Income/(Loss) ($ MM):
(Displayed as graph)

LipoScience, Inc. Interest Expense ($):
(Displayed as graph)

LipoScience, Inc. Interest Income ($):
(Displayed as graph)

LipoScience, Inc. Non-operating Income/(Expense) - Other ($):
(Displayed as graph)

LipoScience, Inc. Non-operating Income/(Expense) ($):
(Displayed as graph)

LipoScience, Inc. Income/(Loss) from Continuing Operations Before Income Taxes ($ MM):
(Displayed as graph)

LipoScience, Inc. Provision for Income Taxes ($):
(Displayed as graph)

LipoScience, Inc. Extinguishment of Debt ($):
(Displayed as graph)

LipoScience, Inc. Net Income (Loss) ($ MM):
(Displayed as graph)

LipoScience, Inc. Preferred Stock Dividends ($ MM):
(Displayed as graph)

LipoScience, Inc. Other Preferred Stock Dividends and Adjustments ($ MM):
(Displayed as graph)

LipoScience, Inc. Net Income Applicable to Common Stockholders ($ MM):
(Displayed as graph)

LipoScience, Inc. Cash and Cash Equivalents ($ MM):
(Displayed as graph)

LipoScience, Inc. Net Accounts Receivable Trade ($ MM):
(Displayed as graph)

LipoScience, Inc. Prepaid Expenses ($):
(Displayed as graph)

LipoScience, Inc. Current Assets ($ MM):
(Displayed as graph)

LipoScience, Inc. Net Property, Plant and Equipment ($ MM):
(Displayed as graph)

LipoScience, Inc. Net Intangible Assets ($):
(Displayed as graph)

LipoScience, Inc. Deferred Financing Costs ($):
(Displayed as graph)

LipoScience, Inc. Other Deferred Long Term Asset Charges ($ MM):
(Displayed as graph)

LipoScience, Inc. Restricted Cash ($ MM):
(Displayed as graph)

LipoScience, Inc. Noncurrent Other Assets ($):
(Displayed as graph)

LipoScience, Inc. Assets ($ MM):
(Displayed as graph)

LipoScience, Inc. Accounts Payable ($ MM):
(Displayed as graph)

LipoScience, Inc. Accrued Expenses ($ MM):
(Displayed as graph)

LipoScience, Inc. Current Portion of Long-Term Debt ($ MM):
(Displayed as graph)

LipoScience, Inc. Current Capital Lease Obligations ($):
(Displayed as graph)

LipoScience, Inc. Current Other Liabilities ($):
(Displayed as graph)

LipoScience, Inc. Current Liabilities ($ MM):
(Displayed as graph)

LipoScience, Inc. Long-Term Debt ($ MM):
(Displayed as graph)

LipoScience, Inc. Noncurrent Warranty and Related Accruals ($):
(Displayed as graph)

LipoScience, Inc. Noncurrent Other Liabilities ($ MM):
(Displayed as graph)

LipoScience, Inc. Liabilities ($ MM):
(Displayed as graph)

LipoScience, Inc. Redeemable Convertible Preferred Stock Obligations ($ MM):
(Displayed as graph)

LipoScience, Inc. Total Temporary Equity ($ MM):
(Displayed as graph)

LipoScience, Inc. Convertible Preferred Stock - Value (Excluding Additional Paid in Capital) ($):
(Displayed as graph)

LipoScience, Inc. Common Stock - Value (Excluding Additional Paid in Capital) ($):
(Displayed as graph)

LipoScience, Inc. Additional Paid in Capital ($ MM):
(Displayed as graph)

LipoScience, Inc. Retained Earnings ($ MM):
(Displayed as graph)

LipoScience, Inc. Stockholders' Equity ($ MM):
(Displayed as graph)

LipoScience, Inc. Liabilities and Stockholders' Equity ($ MM):
(Displayed as graph)

LipoScience, Inc. Operating Activities Beginning Net Income ($ MM):
(Displayed as graph)

LipoScience, Inc. Depreciation and Amortization ($ MM):
(Displayed as graph)

LipoScience, Inc. Gain/(Loss) on Sale/Retirement of Property, Plant and Equipment ($):
(Displayed as graph)

LipoScience, Inc. Adjustment for Equity Based Compensation Expense ($):
(Displayed as graph)

LipoScience, Inc. Adjustment Extraordinary Items ($ MM):
(Displayed as graph)

LipoScience, Inc. Other Adjustments to Common Stockholders' Net Income - Increase/(Decrease) ($):
(Displayed as graph)

LipoScience, Inc. Change Accounts Receivable ($ MM):
(Displayed as graph)

LipoScience, Inc. Change Prepaid Expenses Other Current Assets ($):
(Displayed as graph)

LipoScience, Inc. Increase/(Decrease) in Accounts Payable and Accrued Expenses ($ MM):
(Displayed as graph)

LipoScience, Inc. Increase/(Decrease) in Other Non-operating Liabilities ($):
(Displayed as graph)

LipoScience, Inc. Net Cash Flows Provided By/(Used In) Operating Activities ($ MM):
(Displayed as graph)

LipoScience, Inc. Purchase of Property, Plant and Equipment ($ MM):
(Displayed as graph)

LipoScience, Inc. Purchase Intangible Assets ($):
(Displayed as graph)

LipoScience, Inc. Proceeds from Sale of Property, Plant and Equipment ($):
(Displayed as graph)

LipoScience, Inc. Net Cash Flows Provided By/(Used In) Investing Activities ($ MM):
(Displayed as graph)

LipoScience, Inc. Net Change Restricted Cash ($):
(Displayed as graph)

LipoScience, Inc. Net Proceeds from Issuance of Long-Term Debt and Capital Securities ($ MM):
(Displayed as graph)

LipoScience, Inc. Reduction of Capital Lease Obligations ($):
(Displayed as graph)

LipoScience, Inc. Repayments of Long-Term Debt and Capital Securities ($ MM):
(Displayed as graph)

LipoScience, Inc. Proceeds from Stock Options Exercised ($):
(Displayed as graph)

LipoScience, Inc. Stock Issuance Costs ($ MM):
(Displayed as graph)

LipoScience, Inc. Cash Provided by/(Used in) Financing Activities - Other ($):
(Displayed as graph)

LipoScience, Inc. Net Cash Flows Provided By/(Used In) Financing Activities ($ MM):
(Displayed as graph)

LipoScience, Inc. Increase/(Decrease) in Cash and Cash Equivalents ($ MM):
(Displayed as graph)

LipoScience, Inc. Cash and cash equivalents at the beginning of the year ($ MM):
(Displayed as graph)

LipoScience, Inc. Total Cash and cash equivalents at the end of the year ($ MM):
(Displayed as graph)

LipoScience, Inc. Income Taxes Paid ($):
(Displayed as graph)

LipoScience, Inc. Cash Interest Expense ($):
(Displayed as graph)

LipoScience, Inc. Supplemental Other Net ($ MM):
(Displayed as graph)

PrivCo Private Deals Newsletter.
It's FREE!